+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucose Market by Product Type (Continuous Glucose Monitoring, Flash Glucose Monitoring, Self Monitoring Blood Glucose), End User (Clinics, Home Care, Hospitals), Distribution Channel, Application, Technology - Global Forecast 2025-2030- Product Image
Glucose Market by Product Type (Continuous Glucose Monitoring, Flash Glucose Monitoring, Self Monitoring Blood Glucose), End User (Clinics, Home Care, Hospitals), Distribution Channel, Application, Technology - Global Forecast 2025-2030- Product Image
Sale

Glucose Market by Product Type (Continuous Glucose Monitoring, Flash Glucose Monitoring, Self Monitoring Blood Glucose), End User (Clinics, Home Care, Hospitals), Distribution Channel, Application, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016582
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glucose Market grew from USD 48.03 billion in 2024 to USD 50.84 billion in 2025. It is expected to continue growing at a CAGR of 5.80%, reaching USD 67.38 billion by 2030.

Overview of the Evolving Glucose Monitoring Sector and Its Impact on Patient Care and Market Dynamics

The global focus on glucose monitoring has intensified as healthcare providers and individuals seek more accurate, user-friendly solutions for managing diabetes and related metabolic disorders. Over the past decade, technological breakthroughs have transformed single-point blood glucose tests into continuous monitoring systems that deliver real-time data and predictive analytics. This evolution is reshaping clinical protocols, patient engagement, and the broader healthcare ecosystem. By exploring the latest innovations, regulatory developments, and market dynamics, this executive summary lays the groundwork for understanding how stakeholders can capitalize on emerging opportunities. It provides a concise yet comprehensive overview of the forces driving advancement and adoption in glucose monitoring, setting the stage for deeper analysis in subsequent sections.

Unprecedented Technological Integration and Regulatory Adaptation Driving Patient-Centric Diabetes Management Innovation

Recent years have witnessed a shift from traditional self-monitoring methods to seamless, wearable devices that offer uninterrupted glucose readings. Sensor miniaturization and improved biocompatibility have facilitated continuous glucose monitoring devices that integrate into daily life without hindrance. At the same time, interoperability with smartphones and cloud platforms has enabled remote monitoring and telehealth consultations, bridging gaps between patients and care teams. Meanwhile, data analytics powered by artificial intelligence are refining predictive algorithms, offering proactive alerts that prevent hypo- and hyperglycemic episodes. Regulatory authorities are adapting to this rapid pace of innovation, streamlining approvals while setting higher benchmarks for safety and efficacy. Taken together, these transformative shifts are driving a patient-centric paradigm in diabetes management, fostering greater adherence and better clinical outcomes.

Projected Cost Pressures and Supply Chain Realignments Resulting from New United States Trade Measures

The tariff adjustments scheduled for implementation in early 2025 will create ripple effects across the glucose monitoring value chain. Increased duties on sensor components and electronic modules sourced from abroad are projected to elevate manufacturing costs, prompting device makers to reevaluate their supply chain strategies. In response, some manufacturers are exploring alternative component suppliers within domestic markets, while others are accelerating investments in local assembly capabilities. Distributors and end users can expect to see adjustments in pricing structures that reflect these additional costs, potentially influencing purchasing decisions and reimbursement negotiations. Nevertheless, long-term resilience may emerge as companies diversify their sourcing and optimize production workflows, ultimately buffering the market against future policy shifts.

Holistic Interpretation of Product, End User, Application, Channel, and Technology Segmentation Trends

Product segmentation underscores the rising prominence of real-time continuous glucose monitoring, particularly with implantable sensors that minimize user intervention and enhance data accuracy. Concurrently, intermittent scanning systems continue to find their niche among patients seeking cost-effective, less intrusive options. For self-monitoring blood glucose, advancements in meter precision and test strip sensitivity are redefining usability. Beyond product types, the end user segmentation reveals a growing reliance on home care settings, where remote patient management tools enable clinicians to monitor trends without in-person visits. Specialty clinics are early adopters of integrated monitoring platforms, while general hospitals are expanding their diabetes programs to include comprehensive digital tracking. Distribution channels are likewise evolving: online pharmacies are capturing tech-savvy consumers seeking convenience, while hospital pharmacies remain essential for critical care environments. In the realm of applications, the expansion into sports and fitness highlights the desire for real-time metabolic feedback beyond traditional diabetes care, and research laboratories are leveraging advanced sensors for exploratory studies in gestational and type-specific diabetes contexts. Underpinning these trends, sensor technology is diversifying: electrochemical and amperometric enzymatic sensors lead current deployments, optical spectroscopy methods are emerging for noninvasive readings, and microfluidic systems embedded in transdermal patches are on the horizon.

Comparative Overview of Regional Market Drivers and Barriers Shaping Glucose Monitoring Adoption Globally

In the Americas, strong healthcare infrastructure and favorable reimbursement policies are catalyzing the uptake of both continuous and flash monitoring devices. Regional innovation hubs are fostering partnerships between device manufacturers and digital health companies, accelerating product iterations. Contrastingly, Europe, the Middle East, and Africa exhibit varied trajectories: Western Europe’s stringent regulatory environment demands robust clinical validation, while emerging markets in the Middle East and Africa prioritize cost-effective solutions and mobile health integration. The Asia-Pacific region presents a mosaic of opportunities, from technologically advanced markets in East Asia that push the boundaries of sensor accuracy to rapidly growing demand in South Asia driven by rising diabetes prevalence and expanding urban healthcare networks. Across all regions, local reimbursement frameworks and distribution ecosystems shape device accessibility and adoption rates.

Strategic Collaborations, Mergers, and Innovation Pathways Shaping Competitive Dynamics in Glucose Monitoring

Leading stakeholders are leveraging different strategies to maintain competitive advantage. Some are investing heavily in R&D partnerships with academic institutions to refine biocompatible materials and predictive analytics. Others are forging alliances with telehealth platforms to embed continuous monitoring data into virtual care pathways. Strategic mergers and acquisitions have been instrumental in consolidating sensor technology portfolios and expanding geographic presence. Meanwhile, emerging challengers are differentiating through niche offerings-such as hybrid devices combining glucose metrics with other vital signs-and by prioritizing patient engagement features like gamified apps. Across the board, there is an intensifying focus on data security and interoperability, as organizations recognize the critical importance of seamless integration within broader healthcare IT infrastructures.

Practical Steps for Manufacturers and Suppliers to Future-Proof Operations and Enhance Market Penetration

Industry leaders should prioritize modular platform designs that can be rapidly updated with new sensor chemistries and analytics algorithms, ensuring longevity in a fast-moving market. Emphasizing patient education and digital literacy will improve adherence and unlock the full potential of continuous monitoring data. Supply chain resilience can be bolstered by developing dual sourcing arrangements for key electronic components and exploring near-shoring opportunities. Additionally, forging cross-sector partnerships-such as those with fitness technology providers-can expand addressable markets and foster brand loyalty. Finally, advocating for harmonized regulatory standards across regions will streamline product approvals and facilitate faster market entry.

Comprehensive Mixed-Methods Framework Combining Expert Consultations and Data Triangulation for Unbiased Analysis

This report integrates insights from structured interviews with clinicians, device developers, and policy experts, coupled with comprehensive examinations of regulatory filings and patent databases. Quantitative data were assembled from public health records and proprietary distributor shipment logs, then triangulated against key performance indicators reported by leading academic centers. Qualitative validation workshops ensured that preliminary findings resonated with frontline practitioners. The methodology emphasizes transparency, documenting assumptions at each stage and acknowledging inherent limitations, such as the variable reporting standards across emerging markets. By combining rigorous data analysis with stakeholder perspectives, the study delivers a balanced, evidence-based perspective on the current and future state of glucose monitoring.

Synthesis of Core Findings and Vision for the Future Trajectory of Continuous Glucose Monitoring

As glucose monitoring continues its transformation from episodic testing toward continuous, integrated care solutions, stakeholders face both challenges and opportunities. Technological innovation, evolving regulatory landscapes, and shifting patient expectations are converging to redefine standards of diabetes management. Regional nuances in reimbursement and infrastructure will dictate adoption pathways, while strategic collaborations will determine which organizations emerge as market leaders. By synthesizing segmentation and competitive insights alongside actionable recommendations, this executive summary provides a roadmap for informed decision making. Ultimately, success will hinge on the ability to blend cutting-edge sensor technology with user-centric design and scalable business models.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Product Type
    • Continuous Glucose Monitoring
      • Intermittent Scanning
      • Real Time
        • Implantable Sensors
        • Wearable Sensors
    • Flash Glucose Monitoring
    • Self Monitoring Blood Glucose
      • Lancets
      • Meters
      • Test Strips
  • End User
    • Clinics
      • Diagnostic Centers
      • Specialty Clinics
    • Home Care
    • Hospitals
      • Diabetes Clinics
      • General Hospitals
  • Distribution Channel
    • Hospital Pharmacy
    • Online Stores
    • Retail Pharmacy
  • Application
    • Diabetes Management
      • Gestational Diabetes
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Research And Development
    • Sports And Fitness
  • Technology
    • Enzymatic Sensors
      • Amperometric Sensors
      • Electrochemical Sensors
    • Optical Sensors
      • Fluorescence Spectroscopy
      • Near Infrared Spectroscopy
    • Transdermal Sensors
      • Microfluidic Systems
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • F. Hoffmann-La Roche AG
  • Abbott Diabetes Care Inc.
  • Dexcom, Inc.
  • Medtronic plc
  • LifeScan, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Senseonics Holdings, Inc.
  • Nova Biomedical Corporation
  • Arkray, Inc.
  • Nipro Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for continuous glucose monitoring devices integrated with wearable tech like smartwatches
5.2. Expansion of plant-based glucose sweeteners from novel crops for health-conscious consumers
5.3. Adoption of AI-driven predictive analytics in glucose level management platforms
5.4. Growing investment in enzymatic sensor technology for non-invasive blood glucose monitoring
5.5. Regulatory shifts accelerating approval pathways for glucose monitoring and insulin delivery devices
5.6. Collaboration between biotech startups and telehealth providers to expand remote glucose management services
5.7. Development of personalized nutrition plans based on real-time glucose tracking and analytics
5.8. Integration of blockchain for secure data sharing in glucose monitoring ecosystems
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glucose Market, by Product Type
8.1. Introduction
8.2. Continuous Glucose Monitoring
8.2.1. Intermittent Scanning
8.2.2. Real Time
8.2.2.1. Implantable Sensors
8.2.2.2. Wearable Sensors
8.3. Flash Glucose Monitoring
8.4. Self Monitoring Blood Glucose
8.4.1. Lancets
8.4.2. Meters
8.4.3. Test Strips
9. Glucose Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Diagnostic Centers
9.2.2. Specialty Clinics
9.3. Home Care
9.4. Hospitals
9.4.1. Diabetes Clinics
9.4.2. General Hospitals
10. Glucose Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Stores
10.4. Retail Pharmacy
11. Glucose Market, by Application
11.1. Introduction
11.2. Diabetes Management
11.2.1. Gestational Diabetes
11.2.2. Type 1 Diabetes
11.2.3. Type 2 Diabetes
11.3. Research And Development
11.4. Sports And Fitness
12. Glucose Market, by Technology
12.1. Introduction
12.2. Enzymatic Sensors
12.2.1. Amperometric Sensors
12.2.2. Electrochemical Sensors
12.3. Optical Sensors
12.3.1. Fluorescence Spectroscopy
12.3.2. Near Infrared Spectroscopy
12.4. Transdermal Sensors
12.4.1. Microfluidic Systems
13. Americas Glucose Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Glucose Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Glucose Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Diabetes Care Inc.
16.3.3. Dexcom, Inc.
16.3.4. Medtronic plc
16.3.5. LifeScan, Inc.
16.3.6. Ascensia Diabetes Care Holdings AG
16.3.7. Senseonics Holdings, Inc.
16.3.8. Nova Biomedical Corporation
16.3.9. Arkray, Inc.
16.3.10. Nipro Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GLUCOSE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GLUCOSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GLUCOSE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUCOSE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLUCOSE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLUCOSE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLUCOSE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GLUCOSE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GLUCOSE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLUCOSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLUCOSE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GLUCOSE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GLUCOSE MARKET: RESEARCHAI
FIGURE 26. GLUCOSE MARKET: RESEARCHSTATISTICS
FIGURE 27. GLUCOSE MARKET: RESEARCHCONTACTS
FIGURE 28. GLUCOSE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GLUCOSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLUCOSE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GLUCOSE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GLUCOSE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GLUCOSE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GLUCOSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GLUCOSE MARKET SIZE, BY INTERMITTENT SCANNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GLUCOSE MARKET SIZE, BY INTERMITTENT SCANNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GLUCOSE MARKET SIZE, BY REAL TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GLUCOSE MARKET SIZE, BY REAL TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GLUCOSE MARKET SIZE, BY IMPLANTABLE SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GLUCOSE MARKET SIZE, BY IMPLANTABLE SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GLUCOSE MARKET SIZE, BY WEARABLE SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GLUCOSE MARKET SIZE, BY WEARABLE SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GLUCOSE MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GLUCOSE MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GLUCOSE MARKET SIZE, BY LANCETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GLUCOSE MARKET SIZE, BY LANCETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GLUCOSE MARKET SIZE, BY METERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GLUCOSE MARKET SIZE, BY METERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GLUCOSE MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GLUCOSE MARKET SIZE, BY TEST STRIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GLUCOSE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GLUCOSE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GLUCOSE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GLUCOSE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GLUCOSE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GLUCOSE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GLUCOSE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GLUCOSE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GLUCOSE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GLUCOSE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GLUCOSE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GLUCOSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GLUCOSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GLUCOSE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GLUCOSE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GLUCOSE MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GLUCOSE MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GLUCOSE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GLUCOSE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GLUCOSE MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GLUCOSE MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GLUCOSE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GLUCOSE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GLUCOSE MARKET SIZE, BY SPORTS AND FITNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GLUCOSE MARKET SIZE, BY SPORTS AND FITNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GLUCOSE MARKET SIZE, BY AMPEROMETRIC SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GLUCOSE MARKET SIZE, BY AMPEROMETRIC SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GLUCOSE MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GLUCOSE MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GLUCOSE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GLUCOSE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GLUCOSE MARKET SIZE, BY NEAR INFRARED SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GLUCOSE MARKET SIZE, BY NEAR INFRARED SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GLUCOSE MARKET SIZE, BY MICROFLUIDIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GLUCOSE MARKET SIZE, BY MICROFLUIDIC SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS GLUCOSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES GLUCOSE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES GLUCOSE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 168. CANADA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 169. CANADA GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 170. CANADA GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 171. CANADA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 172. CANADA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 173. CANADA GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. CANADA GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. CANADA GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. CANADA GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. CANADA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. CANADA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. CANADA GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 184. CANADA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 185. CANADA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. CANADA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. CANADA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 188. CANADA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 189. CANADA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 190. CANADA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 191. CANADA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 192. CANADA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 198. MEXICO GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 199. MEXICO GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. MEXICO GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. MEXICO GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 212. MEXICO GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 213. MEXICO GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 335. GERMANY GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. GERMANY GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. GERMANY GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 338. GERMANY GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 339. GERMANY GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 340. GERMANY GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 341. GERMANY GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 342. GERMANY GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 343. GERMANY GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. GERMANY GLUCOSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. GERMANY GLUCOSE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 346. GERMANY GLUCOSE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 347. GERMANY GLUCOSE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 348. GERMANY GLUCOSE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 349. GERMANY GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. GERMANY GLUCOSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. GERMANY GLUCOSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. GERMANY GLUCOSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. GERMANY GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 354. GERMANY GLUCOSE MARKET SIZE, BY DIABETES MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 355. GERMANY GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 356. GERMANY GLUCOSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 357. GERMANY GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2018-2024 (USD MILLION)
TABLE 358. GERMANY GLUCOSE MARKET SIZE, BY ENZYMATIC SENSORS, 2025-2030 (USD MILLION)
TABLE 359. GERMANY GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2018-2024 (USD MILLION)
TABLE 360. GERMANY GLUCOSE MARKET SIZE, BY OPTICAL SENSORS, 2025-2030 (USD MILLION)
TABLE 361. GERMANY GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2018-2024 (USD MILLION)
TABLE 362. GERMANY GLUCOSE MARKET SIZE, BY TRANSDERMAL SENSORS, 2025-2030 (USD MILLION)
TABLE 363. FRANCE GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 364. FRANCE GLUCOSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 365. FRANCE GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 366. FRANCE GLUCOSE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 367. FRANCE GLUCOSE MARKET SIZE, BY REAL TIME, 2018-2024 (USD MILLION)
TABLE 368. FRANCE GLUCOSE MARKET SIZE, BY REAL TIME, 2025-2030 (USD MILLION)
TABLE 369. FRANCE GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 370. FRANCE GLUCOSE MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 371. FRANCE GLUCOSE MARKET SIZE, BY END USER, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Glucose market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Diabetes Care Inc.
  • Dexcom, Inc.
  • Medtronic plc
  • LifeScan, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Senseonics Holdings, Inc.
  • Nova Biomedical Corporation
  • Arkray, Inc.
  • Nipro Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 50.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.38 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glucose Syrup Market by Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), Source (Corn Starch, Rice Starch, Tapioca Starch), Dextrose Equivalent, Application - Global Forecast 2025-2030 - Product Image

Glucose Syrup Market by Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), Source (Corn Starch, Rice Starch, Tapioca Starch), Dextrose Equivalent, Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Glucose Tolerance Tests - Global Strategic Business Report - Product Image

Glucose Tolerance Tests - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Glucose Analysis Tubes - Global Strategic Business Report - Product Image

Glucose Analysis Tubes - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Glucose Syrup Market Size, Share & Trends Analysis Report By Grade (Food, Pharma, Others), By Application (Sweetening Agent, Wine, Others), By Region (North America, Europe, APAC, Central & South America, MEA), And Segment Forecasts, 2025 - 2030 - Product Image

Glucose Syrup Market Size, Share & Trends Analysis Report By Grade (Food, Pharma, Others), By Application (Sweetening Agent, Wine, Others), By Region (North America, Europe, APAC, Central & South America, MEA), And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Corn Glucose Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033 - Product Image

Corn Glucose Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033

  • Report
  • 140 Pages
  • Global
From

About the Glucose Market

The Glucose market is a subset of the larger Sugar and Sweeteners market. Glucose is a simple sugar, also known as dextrose, that is found in many foods and is used as a sweetener. It is a monosaccharide, meaning it is composed of one sugar molecule, and is the most common form of carbohydrate in the human diet. Glucose is used in a variety of food products, including baked goods, confectionery, and beverages. It is also used in the production of pharmaceuticals, cosmetics, and other industrial products. Glucose is produced from a variety of sources, including corn, wheat, and other grains. It is also produced from sugar cane and sugar beets. Glucose is available in a variety of forms, including granulated, liquid, and syrup. Some companies in the Glucose market include Cargill, Tate & Lyle, ADM, Ingredion, and Roquette. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.